Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 5:33 PM
Ignite Modification Date:
2025-12-25 @ 3:05 PM
NCT ID:
NCT00437268
Group ID:
EG000
Title:
Enzastaurin+Irinotecan+Cetuximab
Description:
Enzastaurin: 1125 milligrams (mg) loading dose on Day 1 of Cycle 1, then 500 mg orally, daily, of each 21-day cycle until progressive disease
Irinotecan: 300 milligrams per square meter (mg/m\^2), intravenously on Day 1 of each 21-day cycle until progressive disease
Cetuximab: 400 mg/m\^2 intravenously on Day 1, then 250 mg/m\^2 on Days 8 and 15 of Cycle 1, then 250 mg/m\^2 intravenously on Days 1, 8 and 15 of each 21-day cycle until progressive disease
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
8
Serious Number At Risk:
13
Other Number Affected:
13
Other Number At Risk:
13
Study:
NCT00437268
Results Section:
NCT00437268
Adverse Events Module:
NCT00437268